Guided Therapeutics (GTHP) Interest Coverage Ratio Growth (3y) (2013 - 2025)
Guided Therapeutics (GTHP) Interest Coverage Ratio Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 100.22% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -35.05% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.28% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | -26.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.13% |
| Sep 30, 2025 | 21.92% |
| Jun 30, 2025 | -20.17% |
| Mar 31, 2025 | 13.73% |
| Dec 31, 2024 | -193.48% |
| Sep 30, 2024 | -51.44% |
| Jun 30, 2024 | -69.89% |
| Mar 31, 2024 | -40.28% |
| Dec 31, 2023 | -97.42% |
| Sep 30, 2023 | -60.71% |
| Jun 30, 2023 | -121.88% |
| Mar 31, 2023 | -147.43% |
| Dec 31, 2022 | -154.35% |
| Sep 30, 2022 | -150.90% |
| Jun 30, 2022 | -31.25% |
| Mar 31, 2022 | -85.00% |
| Dec 31, 2021 | 73.65% |
| Sep 30, 2021 | 5.74% |
| Jun 30, 2021 | -2.40% |
| Mar 31, 2021 | -9.66% |